Antioxidants and polyunsaturated fatty acids in multiple sclerosis

Area of Science:

• Neuroimmunology
• Nutritional Neuroscience

Background:

• Multiple sclerosis (MS) is a chronic CNS inflammatory disease characterized by demyelination.
• MS pathology involves immune-mediated inflammation, oxidative stress, and excitotoxicity.
• Increased saturated fatty acid intake is linked to higher MS risk, while PUFA and antioxidant deficiencies are noted in patients.

Purpose of the Study:

• To explore the potential therapeutic roles of dietary antioxidants and polyunsaturated fatty acids (PUFAs) in managing multiple sclerosis (MS).
• To investigate how these nutrients may counteract MS pathomechanisms and support recovery.

Main Methods:

• Review of existing literature on MS immunopathology, dietary factors, and therapeutic interventions.
• Analysis of the mechanisms by which antioxidants and PUFAs influence cellular processes and immune responses relevant to MS.
• Consideration of findings from experimental allergic encephalomyelitis (EAE) models.

Main Results:

• Antioxidant and PUFA treatments reduced disease signs in an EAE model.
• Low-molecular-weight antioxidants support cellular defenses via radical scavenging and modulating cellular pathways.
• PUFAs may exert immunosuppressive effects and influence CNS cell function.

Conclusions:

• Dietary antioxidants and PUFAs show potential in mitigating MS symptoms by targeting key disease mechanisms.
• These nutrients can support cellular antioxidant defenses and modulate immune responses.
• Targeting specific pathomechanisms with antioxidants and PUFAs may aid in MS recovery.